Table 2.

Results from drug susceptibility test performed at any time point in follow-up among all patients with MDR-TB (N = 105)

Drug	N (%) with data	N (% of those tested) with resistance
Group 1
Pyrazinamide	54 (51)	30 (56)
Ethambutol	100 (95)	72 (72)
Streptomycin	75 (71)	72 (96)
Group 2
Fluoroquinolones	79 (75)	22 (28)
Group 3
Second-line injectables	82 (78)	35 (43)
Group 4
Ethionamide/Prothionamide	72 (69)	23 (32)
Cycloserine/Terizidone	51 (49)	8 (16)
Para-Aminosalicylic Acid (PAS)	61 (58)	10 (16)